25.04.2019 20:30

Global Microbots Drug Delivery Report 2025: Microbot Drug Deliver by Indication/Therapy - Cancer, Stem Cell Therapy, Blood Circulatory System, Neurological Problems & Others


DUBLIN, April 25, 2019 /PRNewswire/ -- The "Global Microbots Drug Delivery Advances, Therapeutic Applications & Opportunity Insight 2025" report has been added to's offering.

"Global Microbots Drug Delivery Advances, Therapeutic Applications & Opportunity Insight 2025" report gives comprehensive insight on various issues involved with the research, development and commercialization of microrobots for the application of targeted drug delivery. Report highlights ongoing advancements in the field of medical microrobots and their relevance with respect to multiple indication and therapies.

Medical robotics is a very promising new branch. It is a field that uses tiny robots to travel inside a patient and carry out surgery, diagnosis or drug delivery. They would have the highest scientific and societal impacts on healthcare and bioengineering applications. Milli/submilli/ micro robots are the best alternative to existing medical devices (flexible endoscopes and catheters), mobile medical milli/microrobots have the ability to access small and complex regions of the human body like blood capillaries, gastrointestinal (GI), brain, spinal cord and inside the eye while being minimally invasive. Through microrobots, it is possible to access unprecedented sub-millimeter size regions inside the human body which has not yet been possible by any conventional medical devices.

The most promising application of microrobots in the biomedical field is for targeted drug delivery which allows doctors to inject or dispense drugs to specific or hard-to-reach areas in the body that need them. Targeted therapy boosts the concentration of therapeutics, for instance, drugs, proteins, genes, mRNA, stem cells, radioactive seeds and imaging contrast agents in a specific targeted site inside the body while keeping the side effects to a minimal level in rest of the body. Furthermore, microbots can be controlled by the clinicians which help them control the release kinetics of the drug and modulate the concentration at the therapeutic window. This adjustment would lead to prolonging the effect of single dose administration in the targeted region.

All the traditional methods of treatment that are presently used don't have the potential to reach some of the inaccessible places in the human body. So whenever there is some problem in the hard-to-reach places of the body it is always guesswork, for instance, in the brain or a neurological-related concern. Even though there are advanced technologies like CT scan and MRI, these technologies provide only a few images of the problematic zone in the brain but nothing concrete. There are still no technologies which can penetrate the blood-brain barrier and perform a diagnosis.

Microrobots have a lot of advantages in the biomedical field due to its miniature structure. It has the ability to go inside the body and reach inaccessible places and collect tissue samples to further analyze. For conducting a biopsy with microrobots, especially for bone marrow biopsy or bone biopsy, there is no need for the patient to go through surgery. Also, it is much less painful. In prostate biopsy with needles, multiple needle biopsies are taken at one time from the prostate gland. Sometimes to reach the prostate, a probe is inserted into the rectum. While microbots are so tiny there is no need for these painful procedures. Microbots go to the targeted site, grab onto tissue sample and taken out of the body.

In the near future, microbot will definitely occupy the targeted drug delivery and minimally invasive surgery arena. As these are the most sought for and demanding line of work. Targeted drug delivery and minimally invasive surgeries will not only be less painful for the patient but will also help in cutting the healthcare expenditure. This will definitely draw the attention of the government towards the usefulness of microbots and more grants may be released for R&D on microrobotics.

Also, with growing research and development larger companies working on robotics will bend towards the medical use of the microrobots, hence providing institutes with funding to continue their research to better their product. In this fast forward and technologically driven era, microbots are meant to be the future answer to the medicinal queries and distress. With minimally to non- invasive surgeries it will be easy to treat any age of patient with complicated health conditions also. At present, the microbots might be going through a rough patch but it will slowly transition into the best treatment method.

"Global Microbots Drug Delivery Advances, Therapeutic Applications & Opportunity Insight 2025" Report Highlights:

  • Overview of Microbots
  • Real Life Application of Microbots
  • Microbots: Application In Medicine & Biotechnology
  • Need of Microbots: Thrust To Targeted Drug Delivery Mechanism
  • Technological Advancement in Medical Microrobotics
  • Microbot Drug Deliver by Indication/Therapy: Cancer, Stem Cell Therapy, Blood Circulatory System, Neurological Problems & Others

Key Topics Covered:

1. Overview of Microbots
1.1 Introduction to Microbots
1.2 History & Evolution of Microbots

2. Design Of Microbots
2.1 Design
2.2 Control

3. Actuation Of Microbots
3.1 Electromagnetic Actuators (EMA)
3.2 MEMS Based Magnetic Actuator

4. Microbots Working Mechanism

5. Real Life Application of Microbots
5.1 Snake-Like Microbot
5.3 Harvard's Ambulatory Micro Robot (HAMR)
5.4 Microbees
5.5 ViRob
5.6 Micro-Scallops

6. Microbots: Application In Medicine & Biotechnology
6.1 Disease Diagnosis/Imaging
6.2 Telemetry
6.3 Targeted Therapy
6.3.1 Drug Delivery
6.3.2 Brachytherapy
6.3.3 Hyperthermia & Thermoablation
6.3.4 Stem Cell Delivery
6.4 Minimally Invasive Surgery
6.5 Tissue Engineering
6.6 Cell Manipulation
6.7 Wound Healing
6.8 Material Removal
6.8.1 Ablation
6.8.2 Biopsy
6.9 Controllable Structures

7. Need of Microbots: Thrust To Targeted Drug Delivery Mechanism

8. Technological Advancement in Medical Microrobotics
8.1 Microtumblers (TUMs)
8.2 Photolithography
8.3 3D Printing Techniques
8.4 Biocompatible & Biodegradable Materials
8.5 Wireless communication

9. Microbots: Cancer Treatment
9.1 Drug Delivery to Tumor Cells
9.2 Minimally Invasive Surgery in Cancer Treatment

10. Microbots in Ophthalmology
10.1 Drug Delivery Using Microbots
10.2 Microrobots For Minimally Invasive Intraocular Therapies

11. Microbots in Blood Circulatory System
11.1 Drug Delivery to Arteries via Microbots
11.2 Minimally Invasive Cardiovascular Surgery

12. Microbots: Treatment & Diagnosis in Gastrointestinal Tract
12.1 Drug Delivery in GI Tract through Microbots
12.2 Diagnosis of GI Tract Using Microbots
12.3 Minimally Invasive Surgery in GI Tract

13. Microbots in Treating Renal Ailments
13.1 Targeted Drug Delivery Inside Renal System
13.2 Microbots Assisting Renal System Imaging

14. Microbots inside the Ear (Hearing Restoration)

15. Microbots Fixing Neurological Problems
15.1 Self Cleaning Shunt: Treating Hydrocephalus
15.2 Drug-Delivering Microbots To Treat Lacunar Strokes

16. Microbots: Carrier of Stem Cells

17. Microbots in Drug Delivery
17.1 Locomotive Drug Delivery Particle
17.2 Different Modes Of Microbot Drug Delivery

18. Global Microbot Drug Delivery Market Dynamics
18.1 Driving Force for Microbot Research
18.2 Microbot Drug Delivery Market Challenges

19. Intellectual Property & Commercialization

20. Future of Microbots in Medicine

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:

SOURCE Research and Markets

Börse Stuttgart Anlegerclub

Die richtige Strategie für die Börsenkrise

Stecken Sie nicht den Sand in den Kopf, sondern kaufen Sie die richtigen Aktien. Erfahren Sie im aktuellen Anlegermagazin mehr über attraktive Qualitätsaktien und zyklische Aktien
Kostenfrei registrieren und lesen!

Heute im Fokus

DAX schließt tiefer -- Dow schließt kaum verändert -- Trump kritisiert Fed erneut -- Daimler-Aktie: Gewinnwarnung -- Lufthansa mit neuer Dividendenpolitik -- Dürr, METRO, MorphoSys, VW im Fokus

Bristol-Myers kämpft um grünes Licht für Celgene-Übernahme. Porsche ruft fast 100.000 Autos in USA zurück. Apple wehrt sich vor EU-Kommission gegen Spotify-Vorwürfe. RWE-Aktie nach HSBC-Abstufung unter Druck. Bitcoin hält sich in Sichtweite zu 11.000 US-Dollar. Trump kündigt neue Sanktionen gegen den Iran an.

Die 5 beliebtesten Top-Rankings

Diese Sternchen haben ihren eigenen Aktien-Index
Diese Aktien hat Warren Buffett im Depot
Die Änderungen unter den Top-Positionen
Die erfolgreichsten Kinofilme der letzten 25 Jahre
Welche Titel knackten die Milliardenmarke an den Kinokassen?
In diesen Berufen bekommt man das niedrigste Gehalt
Welche Branchen man besser meiden sollte.
DIe innovativsten Unternehmen
Diese Unternehmen sind am fortschrittlichsten
mehr Top Rankings


Die USA suchen Verbündete gegen den Iran. Sollte sich Deutschland einer solchen Allianz anschließen?

Online Brokerage über Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von!


Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Euro US-Dollar
Wirecard AG747206
Daimler AG710000
Deutsche Bank AG514000
Barrick Gold Corp.870450
Microsoft Corp.870747
Volkswagen (VW) AG Vz.766403
Infineon AG623100
Apple Inc.865985
Lufthansa AG823212
Beyond MeatA2N7XQ